NEW YORK, NY / ACCESS Newswire / August 3, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Unicycive Therapeutics, Inc. ("Unicycive" or the "Company") (NASDAQ:UNCY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Unicycive and certain of its officers and/or directors […]

NEW YORK, NY / ACCESS Newswire / August 3, 2025 / Pomerantz LLP is investigating claims on behalf of investors of CTO Realty Growth, Inc. ("CTO" or the "Company") (NYSE:CTO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether CTO and certain of its officers and/or

NEW YORK, NY / ACCESS Newswire / August 3, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Harrow, Inc. ("Harrow" or the "Company") (NASDAQ:HROW). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Harrow and certain of its officers and/or directors have

NEW YORK, NY / ACCESS Newswire / August 3, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Abacus Global Management, Inc. ("Abacus" or the "Company") (NASDAQ:ABL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Abacus and certain of its officers and/or

NEW YORK CITY, NY / ACCESS Newswire / August 3, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Geely Automobile Holdings Limited ("Geely" or the "Company") (OTCMKTS:GELYF; GELYY). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Geely and certain of its

NEW YORK CITY, NY / ACCESS Newswire / August 3, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Nutex Health Inc. ("Nutex" or the "Company") (NASDAQ:NUTX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Nutex and certain of its officers and/or

NEW YORK CITY, NY / ACCESS Newswire / August 3, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Centene Corporation ("Centene" or the "Company") (NYSE:CNC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged

NEW YORK CITY, NY / ACCESS Newswire / August 3, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Alto Neuroscience, Inc. ("Alto" or the "Company") (NYSE:ANRO) and certain officers.�� The class action, filed in the United States District Court for the Northern District of California, and docketed under 25-cv-06105,

NEW YORK CITY, NY / ACCESS Newswire / August 3, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sun Communities, Inc. ("Sun Communities" or "the Company") (NYSE:SUI). Investors who purchased Sun Communities securities prior to February 28, 2019, and continue to hold to the present, are encouraged

NEW YORK, NY / ACCESS Newswire / August 3, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of DMC Global Inc. ("DMC Global" or "the Company") (NASDAQ:BOOM). Investors who purchased DMC Global securities prior to January 29, 2024, and continue to hold to the present, are encouraged to